323 related articles for article (PubMed ID: 19152687)
1. Novel multicellular organotypic models of normal and malignant breast: tools for dissecting the role of the microenvironment in breast cancer progression.
Holliday DL; Brouilette KT; Markert A; Gordon LA; Jones JL
Breast Cancer Res; 2009; 11(1):R3. PubMed ID: 19152687
[TBL] [Abstract][Full Text] [Related]
2. Primary breast myoepithelial cells exert an invasion-suppressor effect on breast cancer cells via paracrine down-regulation of MMP expression in fibroblasts and tumour cells.
Jones JL; Shaw JA; Pringle JH; Walker RA
J Pathol; 2003 Dec; 201(4):562-72. PubMed ID: 14648659
[TBL] [Abstract][Full Text] [Related]
3. Fibroblasts direct differentiation of human breast epithelial progenitors.
Morsing M; Kim J; Villadsen R; Goldhammer N; Jafari A; Kassem M; Petersen OW; Rønnov-Jessen L
Breast Cancer Res; 2020 Sep; 22(1):102. PubMed ID: 32993755
[TBL] [Abstract][Full Text] [Related]
4. Role of HGF in epithelial-stromal cell interactions during progression from benign breast disease to ductal carcinoma in situ.
Casbas-Hernandez P; D'Arcy M; Roman-Perez E; Brauer HA; McNaughton K; Miller SM; Chhetri RK; Oldenburg AL; Fleming JM; Amos KD; Makowski L; Troester MA
Breast Cancer Res; 2013; 15(5):R82. PubMed ID: 24025166
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast hepatocyte growth factor promotes invasion of human mammary ductal carcinoma in situ.
Jedeszko C; Victor BC; Podgorski I; Sloane BF
Cancer Res; 2009 Dec; 69(23):9148-55. PubMed ID: 19920187
[TBL] [Abstract][Full Text] [Related]
6. Human mammary fibroblasts stimulate invasion of breast cancer cells in a three-dimensional culture and increase stroma development in mouse xenografts.
Olsen CJ; Moreira J; Lukanidin EM; Ambartsumian NS
BMC Cancer; 2010 Aug; 10():444. PubMed ID: 20723242
[TBL] [Abstract][Full Text] [Related]
7. Myoepithelial molecular markers in human breast carcinoma PMC42-LA cells are induced by extracellular matrix and stromal cells.
Lebret SC; Newgreen DF; Waltham MC; Price JT; Thompson EW; Ackland ML
In Vitro Cell Dev Biol Anim; 2006; 42(10):298-307. PubMed ID: 17316063
[TBL] [Abstract][Full Text] [Related]
8. Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition.
Gudjonsson T; Rønnov-Jessen L; Villadsen R; Rank F; Bissell MJ; Petersen OW
J Cell Sci; 2002 Jan; 115(Pt 1):39-50. PubMed ID: 11801722
[TBL] [Abstract][Full Text] [Related]
9. Loss of MMP-8 in ductal carcinoma in situ (DCIS)-associated myoepithelial cells contributes to tumour promotion through altered adhesive and proteolytic function.
Sarper M; Allen MD; Gomm J; Haywood L; Decock J; Thirkettle S; Ustaoglu A; Sarker SJ; Marshall J; Edwards DR; Jones JL
Breast Cancer Res; 2017 Mar; 19(1):33. PubMed ID: 28330493
[TBL] [Abstract][Full Text] [Related]
10. The microenvironment determines the breast cancer cells' phenotype: organization of MCF7 cells in 3D cultures.
Krause S; Maffini MV; Soto AM; Sonnenschein C
BMC Cancer; 2010 Jun; 10():263. PubMed ID: 20529269
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer subtype-specific interactions with the microenvironment dictate mechanisms of invasion.
Dang TT; Prechtl AM; Pearson GW
Cancer Res; 2011 Nov; 71(21):6857-66. PubMed ID: 21908556
[TBL] [Abstract][Full Text] [Related]
12. A 3D in vitro model of the human breast duct: a method to unravel myoepithelial-luminal interactions in the progression of breast cancer.
Carter EP; Gopsill JA; Gomm JJ; Jones JL; Grose RP
Breast Cancer Res; 2017 Apr; 19(1):50. PubMed ID: 28427436
[TBL] [Abstract][Full Text] [Related]
13. Myoepithelial cell-specific expression of stefin A as a suppressor of early breast cancer invasion.
Duivenvoorden HM; Rautela J; Edgington-Mitchell LE; Spurling A; Greening DW; Nowell CJ; Molloy TJ; Robbins E; Brockwell NK; Lee CS; Chen M; Holliday A; Selinger CI; Hu M; Britt KL; Stroud DA; Bogyo M; Möller A; Polyak K; Sloane BF; O'Toole SA; Parker BS
J Pathol; 2017 Dec; 243(4):496-509. PubMed ID: 29086922
[TBL] [Abstract][Full Text] [Related]
14. Normal mammary fibroblasts induce reversion of the malignant phenotype in human primary breast cancer.
Römer AM; Lühr I; Klein A; Friedl A; Sebens S; Rösel F; Arnold N; Strauss A; Jonat W; Bauer M
Anticancer Res; 2013 Apr; 33(4):1525-36. PubMed ID: 23564794
[TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor alpha and interleukin 11 secreted by malignant breast epithelial cells inhibit adipocyte differentiation by selectively down-regulating CCAAT/enhancer binding protein alpha and peroxisome proliferator-activated receptor gamma: mechanism of desmoplastic reaction.
Meng L; Zhou J; Sasano H; Suzuki T; Zeitoun KM; Bulun SE
Cancer Res; 2001 Mar; 61(5):2250-5. PubMed ID: 11280794
[TBL] [Abstract][Full Text] [Related]
16. MAME models for 4D live-cell imaging of tumor: microenvironment interactions that impact malignant progression.
Sameni M; Anbalagan A; Olive MB; Moin K; Mattingly RR; Sloane BF
J Vis Exp; 2012 Feb; (60):. PubMed ID: 22371028
[TBL] [Abstract][Full Text] [Related]
17. Tumor-associated myoepithelial cells promote the invasive progression of ductal carcinoma
Lo PK; Zhang Y; Yao Y; Wolfson B; Yu J; Han SY; Duru N; Zhou Q
J Biol Chem; 2017 Jul; 292(27):11466-11484. PubMed ID: 28512126
[TBL] [Abstract][Full Text] [Related]
18. Chronic exposure to fulvestrant promotes overexpression of the c-Met receptor in breast cancer cells: implications for tumour-stroma interactions.
Hiscox S; Jordan NJ; Jiang W; Harper M; McClelland R; Smith C; Nicholson RI
Endocr Relat Cancer; 2006 Dec; 13(4):1085-99. PubMed ID: 17158755
[TBL] [Abstract][Full Text] [Related]
19. To create the correct microenvironment: three-dimensional heterotypic collagen assays for human breast epithelial morphogenesis and neoplasia.
Gudjonsson T; Rønnov-Jessen L; Villadsen R; Bissell MJ; Petersen OW
Methods; 2003 Jul; 30(3):247-55. PubMed ID: 12798139
[TBL] [Abstract][Full Text] [Related]
20. Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells.
Soon PS; Kim E; Pon CK; Gill AJ; Moore K; Spillane AJ; Benn DE; Baxter RC
Endocr Relat Cancer; 2013 Feb; 20(1):1-12. PubMed ID: 23111755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
